» Authors » Mark Woodhall

Mark Woodhall

Explore the profile of Mark Woodhall including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 69
Citations 2583
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen B, Gomez-Figueroa E, Redenbaugh V, Francis A, Satukijchai C, Wu Y, et al.
Ann Neurol . 2023 Jul; 94(3):508-517. PMID: 37394961
Objective: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) can be monophasic or relapsing, with early relapse being a feature. However, the relevance of early relapse on longer-term relapse risk is unknown....
2.
Ingelfinger F, Kramer M, Lutz M, Widmer C, Piccoli L, Kreutmair S, et al.
Neurol Neuroimmunol Neuroinflamm . 2023 Feb; 10(2). PMID: 36754834
Background And Objectives: Myasthenia gravis (MG) can in rare cases be an autoimmune phenomenon associated with hematologic malignancies such as chronic lymphocytic leukemia (CLL). It is unclear whether in patients...
3.
Kwon Y, Woodhall M, Sung J, Kim K, Lim Y, Kim H, et al.
J Neurol . 2022 Nov; 270(3):1478-1486. PMID: 36396811
Background: We aimed to evaluate the diagnostic accuracy of enzyme-linked immunosorbent assay (ELISA) for anti-muscle specific tyrosine kinase (MuSK) antibody (Ab) in a large cohort of anti-acetylcholine receptor (AChR) Ab-negative...
4.
Chang T, Moloney T, Jacobson L, Malavige N, Lohitharajah J, Wanigasinghe J, et al.
Ann Indian Acad Neurol . 2022 Aug; 25(3):473-478. PMID: 35936609
Background: Prevalence of antibody-mediated autoimmune encephalitis (AE) is reported to be comparable to infectious encephalitis in Western populations. We evaluated the frequency and significance of AE and neuronal autoantibodies in...
5.
Damato V, Spagni G, Monte G, Woodhall M, Jacobson L, Falso S, et al.
J Neurol Neurosurg Psychiatry . 2022 Jul; 93(9):995-1000. PMID: 35835469
Objective: Patients with myasthenia gravis without acetylcholine receptor (AChR) or muscle-specific kinase (MuSK) antibodies detected by radioimmunoprecipitation assays (RIAs) are classified as seronegative myasthenia gravis (SNMG). Live cell-based assays (l-CBAs)...
6.
Damato V, Theorell J, Al-Diwani A, Kienzler A, Makuch M, Sun B, et al.
Proc Natl Acad Sci U S A . 2022 Jun; 119(24):e2121804119. PMID: 35666871
Neuromyelitis optica spectrum disorders (NMOSDs) are caused by immunoglobulin G (IgG) autoantibodies directed against the water channel aquaporin-4 (AQP4). In NMOSDs, discrete clinical relapses lead to disability and are robustly...
7.
Fadda G, Waters P, Woodhall M, Brown R, OMahony J, Castro D, et al.
Mult Scler . 2022 May; 28(11):1697-1709. PMID: 35581944
Background: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is now recognized as distinct from multiple sclerosis (MS). Objective: To evaluate the importance of considering myelin oligodendrocyte glycoprotein (MOG)-immunoglobulin-G (IgG) serology when...
8.
Clarke L, Bukhari W, OGorman C, Khalilidehkordi E, Arnett S, Woodhall M, et al.
Mult Scler Relat Disord . 2022 Feb; 58:103408. PMID: 35216788
Background: Neuromyelitis optica spectrum disorder (NMOSD) is associated with significant morbidity and mortality. Several therapies have been recommended for NMOSD and more recently clinical trials have demonstrated efficacy for three...
9.
Woodhall M, Mgbachi V, Fox H, Irani S, Waters P
J Appl Lab Med . 2022 Jan; 7(1):391-393. PMID: 34996083
No abstract available.
10.
Huda S, Whittam D, Jackson R, Karthikeayan V, Kelly P, Linaker S, et al.
BMJ Open . 2021 Dec; 11(11):e055392. PMID: 34848526
Objective: To identify factors predictive of relapse risk and disability in myelin oligodendrocyte glycoprotein associated disease (MOGAD). Setting: Patients were seen by the neuromyelitis optica spectrum disorders (NMOSD) service in...